Prebiotic Effects of a Novel Combination of Galactooligosaccharides and Maltodextrins
Publication: Journal of Medicinal Food
Volume 18, Issue Number 6
Abstract
Prebiotics are used for stimulating the growth of beneficial microorganisms in the gut. However, it is very difficult to find a suitable prebiotic mixture that exclusively supports the growth of beneficial microbes such as bifidobacteria and lactobacilli. We tested the effects of a prebiotic mixture in vitro by incubating it with fecal samples and in vivo by administration of the prebiotic supplement to healthy adult volunteers, followed by analysis of their fecal microbiota. The effect of the oligosaccharides on bacterial metabolism was studied by analyzing short-chain fatty acid (SCFA) production in vitro and the SCFA pattern for the stool samples of volunteers. In the in vitro test, a higher proportion of bifidobacteria (25.77%) was seen in the total bacterial population after cultivation on a prebiotic mixture than on the control medium (7.94%). The gram-negative anaerobe count significantly decreased from 8.70 to 6.40 log CFU/g (from 35.21% to 0.60%) and the Escherichia coli count decreased from 7.41 to 6.27 log CFU/g (from 1.78% to 0.44%). Administration of a prebiotic mixture in vivo (9 g of galactooligosaccharides [GOS]+1 g of maltodextrins; daily for 5 days) significantly increased the fecal bifidobacterial count from 9.45 to 9.83 log CFU/g (from 40.80% to 53.85% of total bacteria) and reduced the E. coli count from 7.23 to 6.28 log CFU/g (from 55.35% to 45.06% of total bacteria). The mixture comprising GOS and maltodextrins thus exhibited bifidogenic properties, promoting the performance of bifidobacteria by boosting their growth and inhibiting the growth of undesirable bacteria.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Nakamura YK, Omaye ST: Metabolic diseases and pro-and prebiotics: mechanistic insights. Nutr Metab (Lond) 2012;9:60.
2.
Tannock: Probiotics and Prebiotics: Where Are We Going? Wymondham: Caister Academic Press, 2002, pp. 1–20.
3.
Delzenne NM: Oligosaccharides: state of the art. Proc Nutr Soc 2003;62:177–182.
4.
Fallani M, Young D, Scott J, et al.: Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr 2010;51:77–84.
5.
Mikami K, Kimura M, Takahashi H: Influence of maternal bifidobacteria on the development of gut bifidobacteria in infants. Pharmaceuticals 2012;5:629–642.
6.
Eckburg PB, Bik EM, Bernstein CN, et al.: Diversity of the human intestinal microbial flora. Science 2005;308:1635–1638.
7.
Boehm G, Jelinek J, Stahl B, et al.: Prebiotics in infant formulas. J Clin Gastroenterol 2004;38(6 Suppl):S76–S79.
8.
Roberfroid M: Prebiotics: the concept revisited. J Nutr 2007;137:830S–837S.
9.
Euler AR, Mitchell DK, Kline R, Pickering LK: Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk. J Pediatr Gastroenterol Nutr 2005;40:157–164.
10.
Bunešová V, Vlková E, Rada V, et al.: Growth of infant fecal bacteria on commercial prebiotics. Folia Microbiol 2012;57:273–275.
11.
Cummings J, Pomare E, Branch W, Naylor C, Macfarlane G: Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987;28:1221–1227.
12.
Vlková E, Nevoral J, Jencikova B, et al.: Detection of infant faecal bifidobacteria by enzymatic methods. J Microbiol Methods 2005;60:365–373.
13.
Rada V, Petr J: A new selective medium for the isolation of glucose non-fermenting bifidobacteria from hen caeca. J Microbiol Methods 2000;43:127–132.
14.
Friedemann TE: The identification and quantitative determination of volatile alcohols and acids. J Biol Chem 1938;123:161–184.
15.
Ottenstein D, Bartley D: Improved gas chromatography separation of free acids C2-C5 in dilute solution. Anal Chem 1971;43:952–955.
16.
Palframan R, Gibson GR, Rastall RA: Development of a quantitative tool for the comparison of the prebiotic effect of dietary oligosaccharides. Lett Appl Microbiol 2003;37:281–284.
17.
Gibson GR, Roberfroid MB: Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401–1412.
18.
Gibson GR, Probert HM, Van Loo J, Rastall RA, Roberfroid MB: Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004;17:259–275.
19.
Saad N, Delattre C, Urdaci M, Schmitter JM, Bressollier P: An overview of the last advances in probiotic and prebiotic field. LWT Food Sci Technol 2013;50:1–16.
20.
Forchielli ML, Walker WA: The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr 2005;93:41–48.
21.
Qiang X, YongLie C, QianBing W: Health benefit application of functional oligosaccharides. Carbohydr Polym 2009;77:435–441.
22.
Bornet FRJ, Brouns F, Tashiro Y, Duvillier V: Nutritional aspects of short-chain fructooligosaccharides: natural occurrence, chemistry, physiology and health implications. Digest Liver Dis 2002;34 Supplement 2(0):S111–S120.
23.
Bugaut M, Bentéjac M: Biological effects of short-chain fatty acids in nonruminant mammals. Annu Rev Nutr 1993;13:217–241.
24.
Scheppach W, Weiler F: The butyrate story: old wine in new bottles? Curr Opin Clin Nutr 2004;7:563–567.
25.
Kim VS, Ysao D, Siddiqui, et al.: Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer (Phila.) 1980;45:1185–1192.
Information & Authors
Information
Published In
Copyright
Copyright 2015, Mary Ann Liebert, Inc. and Korean Society of Food Science and Nutrition.
History
Published in print: June 2015
Published online: 29 May 2015
Published ahead of print: 19 December 2014
Accepted: 24 October 2014
Received: 18 December 2013
Topics
Authors
Author Disclosure Statement
No competing financial interests exist for any of the authors.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.